The Role of Immunometabolism in HIV-1 Pathogenicity: Links to Immune Cell Responses

With the successful roll-out of combination antiretroviral treatment, HIV is currently managed as a chronic illness. Of note, immune activation and chronic inflammation are hallmarks of HIV-1 infection that persists even though patients are receiving treatments. Despite strong evidence linking immun...

Full description

Bibliographic Details
Main Authors: Eman Teer, Nyasha C. Mukonowenzou, M. Faadiel Essop
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/14/8/1813
_version_ 1797407414342909952
author Eman Teer
Nyasha C. Mukonowenzou
M. Faadiel Essop
author_facet Eman Teer
Nyasha C. Mukonowenzou
M. Faadiel Essop
author_sort Eman Teer
collection DOAJ
description With the successful roll-out of combination antiretroviral treatment, HIV is currently managed as a chronic illness. Of note, immune activation and chronic inflammation are hallmarks of HIV-1 infection that persists even though patients are receiving treatments. Despite strong evidence linking immune activation and low-grade inflammation to HIV-1 pathogenesis, the underlying mechanisms remain less well-understood. As intracellular metabolism is emerging as a crucial factor determining the fate and activity of immune cells, this review article focuses on how links between early immune responses and metabolic reprograming may contribute to HIV pathogenicity. Here, the collective data reveal that immunometabolism plays a key role in HIV-1 pathogenesis. For example, the shift from quiescent immune cells to its activation leads to perturbed metabolic circuits that are major drivers of immune cell dysfunction and an altered phenotype. These findings suggest that immunometabolic perturbations play a key role in the onset of non-AIDS-associated comorbidities and that they represent an attractive target to develop improved diagnostic tools and novel therapeutic strategies to help blunt HIV-1 pathogenesis.
first_indexed 2024-03-09T03:41:05Z
format Article
id doaj.art-1206d9514655429a98d57926618496e8
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-09T03:41:05Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-1206d9514655429a98d57926618496e82023-12-03T14:39:47ZengMDPI AGViruses1999-49152022-08-01148181310.3390/v14081813The Role of Immunometabolism in HIV-1 Pathogenicity: Links to Immune Cell ResponsesEman Teer0Nyasha C. Mukonowenzou1M. Faadiel Essop2Centre for Cardio-Metabolic Research in Africa (CARMA), Department of Physiological Sciences, Stellenbosch University, Stellenbosch 7600, South AfricaCentre for Cardio-Metabolic Research in Africa (CARMA), Department of Physiological Sciences, Stellenbosch University, Stellenbosch 7600, South AfricaCentre for Cardio-Metabolic Research in Africa (CARMA), Division of Medical Physiology, BMRI, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 8000, South AfricaWith the successful roll-out of combination antiretroviral treatment, HIV is currently managed as a chronic illness. Of note, immune activation and chronic inflammation are hallmarks of HIV-1 infection that persists even though patients are receiving treatments. Despite strong evidence linking immune activation and low-grade inflammation to HIV-1 pathogenesis, the underlying mechanisms remain less well-understood. As intracellular metabolism is emerging as a crucial factor determining the fate and activity of immune cells, this review article focuses on how links between early immune responses and metabolic reprograming may contribute to HIV pathogenicity. Here, the collective data reveal that immunometabolism plays a key role in HIV-1 pathogenesis. For example, the shift from quiescent immune cells to its activation leads to perturbed metabolic circuits that are major drivers of immune cell dysfunction and an altered phenotype. These findings suggest that immunometabolic perturbations play a key role in the onset of non-AIDS-associated comorbidities and that they represent an attractive target to develop improved diagnostic tools and novel therapeutic strategies to help blunt HIV-1 pathogenesis.https://www.mdpi.com/1999-4915/14/8/1813HIVnon-AIDS-associated comorbiditiesimmunometabolisminflammationmitochondria
spellingShingle Eman Teer
Nyasha C. Mukonowenzou
M. Faadiel Essop
The Role of Immunometabolism in HIV-1 Pathogenicity: Links to Immune Cell Responses
Viruses
HIV
non-AIDS-associated comorbidities
immunometabolism
inflammation
mitochondria
title The Role of Immunometabolism in HIV-1 Pathogenicity: Links to Immune Cell Responses
title_full The Role of Immunometabolism in HIV-1 Pathogenicity: Links to Immune Cell Responses
title_fullStr The Role of Immunometabolism in HIV-1 Pathogenicity: Links to Immune Cell Responses
title_full_unstemmed The Role of Immunometabolism in HIV-1 Pathogenicity: Links to Immune Cell Responses
title_short The Role of Immunometabolism in HIV-1 Pathogenicity: Links to Immune Cell Responses
title_sort role of immunometabolism in hiv 1 pathogenicity links to immune cell responses
topic HIV
non-AIDS-associated comorbidities
immunometabolism
inflammation
mitochondria
url https://www.mdpi.com/1999-4915/14/8/1813
work_keys_str_mv AT emanteer theroleofimmunometabolisminhiv1pathogenicitylinkstoimmunecellresponses
AT nyashacmukonowenzou theroleofimmunometabolisminhiv1pathogenicitylinkstoimmunecellresponses
AT mfaadielessop theroleofimmunometabolisminhiv1pathogenicitylinkstoimmunecellresponses
AT emanteer roleofimmunometabolisminhiv1pathogenicitylinkstoimmunecellresponses
AT nyashacmukonowenzou roleofimmunometabolisminhiv1pathogenicitylinkstoimmunecellresponses
AT mfaadielessop roleofimmunometabolisminhiv1pathogenicitylinkstoimmunecellresponses